Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 21 studies with search of: | Mozambique |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB co-Infected Patients (ANRS 12146 CARINEMO)
|
||||
2 | Completed |
Combination Antimalarials in Uncomplicated Malaria
|
||||
3 | Completed |
A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria
|
||||
4 | Completed |
A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria
|
||||
5 | Active, not recruiting |
Artesunate Plus Sulfadoxine-Pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With Malaria
|
||||
6 | Completed |
Longitudinal Study of HAART, Social Networks, & Adherence
|
||||
7 | Completed |
Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique
|
||||
8 | Completed |
Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine
|
||||
9 | Completed |
Examine Safety & Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-Endemic Region
|
||||
10 | Recruiting |
Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis
|
||||
11 | Completed |
A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-Endemic Region of Mozambique.
|
||||
12 | Active, not recruiting |
Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-Pyrimethamine Intermittent Presumptive Treatment in Pregnant Women
|
||||
13 | Recruiting |
Age of Exposure and Immunity to Malaria in Infants
|
||||
14 | Completed |
Misoprostol for the Treatment of Incomplete Abortion
|
||||
15 | Completed |
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-Endemic Region of Mozambique.
|
||||
16 | Recruiting |
Evaluation of 4 Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children
|
||||
17 | Recruiting |
Routine Iron Prophylaxis During Pregnancy
|
||||
18 | Active, not recruiting |
IPTp Plus ITNs for Malaria Control in Pregnant Women
|
||||
19 | Completed |
Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients
|
||||
20 | Recruiting |
Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients
|
Previous Page | Studies Shown (1-20) | Next (21-21) |